A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. [electronic resource]
Producer: 20160324Description: 1577-89 p. digitalISSN:- 1460-2385
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anemia, Iron-Deficiency -- drug therapy
- Disaccharides -- therapeutic use
- Early Intervention, Educational
- Female
- Ferric Compounds -- therapeutic use
- Ferric Oxide, Saccharated
- Ferritins -- metabolism
- Glucaric Acid -- therapeutic use
- Hematinics -- therapeutic use
- Hemoglobins -- analysis
- Humans
- Maintenance Chemotherapy
- Male
- Middle Aged
- Prospective Studies
- Renal Dialysis
- Renal Insufficiency, Chronic -- therapy
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.